Vestal Point Capital LP Makes New $23.39 Million Investment in Nyxoah S.A. (NASDAQ:NYXH)

Vestal Point Capital LP bought a new stake in shares of Nyxoah S.A. (NASDAQ:NYXH - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 2,924,216 shares of the company's stock, valued at approximately $23,394,000. Nyxoah makes up about 1.4% of Vestal Point Capital LP's holdings, making the stock its 28th largest position. Vestal Point Capital LP owned about 8.59% of Nyxoah as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Renaissance Technologies LLC purchased a new position in shares of Nyxoah during the 4th quarter valued at approximately $187,000. Kovack Advisors Inc. lifted its position in shares of Nyxoah by 100.0% during the 4th quarter. Kovack Advisors Inc. now owns 20,000 shares of the company's stock valued at $160,000 after buying an additional 10,000 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Nyxoah by 19.4% during the 4th quarter. Geode Capital Management LLC now owns 17,100 shares of the company's stock valued at $137,000 after buying an additional 2,774 shares in the last quarter. Ameriprise Financial Inc. purchased a new position in shares of Nyxoah during the 4th quarter valued at approximately $135,000. Finally, Walleye Capital LLC lifted its position in shares of Nyxoah by 23.9% during the 4th quarter. Walleye Capital LLC now owns 14,831 shares of the company's stock valued at $119,000 after buying an additional 2,862 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. HC Wainwright restated a "buy" rating and issued a $15.00 price objective on shares of Nyxoah in a report on Tuesday, April 8th. Stifel Nicolaus decreased their price objective on Nyxoah from $15.00 to $14.00 and set a "buy" rating on the stock in a report on Monday, April 21st.

Nyxoah Trading Down 7.0%

Shares of NYXH stock traded down $0.58 on Friday, hitting $7.74. 116,429 shares of the stock traded hands, compared to its average volume of 74,237. The firm's 50-day moving average price is $6.95 and its two-hundred day moving average price is $8.54. The company has a debt-to-equity ratio of 0.21, a quick ratio of 4.95 and a current ratio of 5.28. The stock has a market capitalization of $263.62 million, a PE ratio of -4.14 and a beta of 1.56. Nyxoah S.A. has a twelve month low of $5.55 and a twelve month high of $11.87.

Nyxoah (NASDAQ:NYXH - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported ($0.63) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.14). The firm had revenue of $1.12 million for the quarter, compared to analyst estimates of $1.64 million. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%. As a group, analysts anticipate that Nyxoah S.A. will post -1.91 EPS for the current year.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.